Malaria Vaccine

India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK, official sources said on Thursday. The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine. The move comes after an application was submitted by Prakash Kumar Singh, director, Government and Regulatory Affairs, at Serum Institute of India (SII) to DCGI on September 27 seeking permission to export the vaccine against malaria, official sources told PTI. "SII has developed the vaccine against malaria under leadership of our CEO Dr Adar C Poonawalla. We have been relentlessly working to make available made-in-India and world-class vaccines against malaria to our country and world at large," an official source quoted Singh as having said in the application. Currently, only one vaccine against malaria is available globally and GSK is the ...

SII is building a future pandemic facility, which will have an annual capacity of 2 bn doses

What is keeping Adar Poonawalla busy these days?

Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more

WHO welcomed the announcement by Gavi, the Vaccine Alliance, of international support worth nearly USD 160 million for the next 3 years to facilitate increased vaccine access to children

Test can differentiate between seven diseases and give results in 2 hrs

According to the WHO's 2021 World Malaria Report, global progress in reducing malaria cases and deaths has slowed or stalled in recent years, particularly in the countries hardest hit by the disease

Only 27 malaria deaths were reported in the entire state in the past five years from 2017 onwards, they said

A study says, hydroxychloroquine inhibits pathways that drive resistance to chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisplatin in animal models

There are several candidates in the works - the Serum Institute of India, Bharat Biotech, and Zydus Cadila are working on either developing or manufacturing anti-malarial vaccines

This vaccine has been in development for 30 long years

The World Health Organization (WHO) said on Wednesday that it has recommended widespread use of the world's first malaria vaccine called RTS,S/AS01 (RTS,S) for children in sub-Saharan Africa.

In a piece of good news, Odisha has achieved 90 per cent reduction of Malaria positive cases in the last three years, according to an official release by the state government on Friday

The agreement includes transfer of manufacturing of the protein part of the vaccine

Covid-19 has triggered a sense of urgency to revive this sick unit, as Hydroxychloroquine, an anti-malarial drug, surfaced as potential medicine to alleviate the symptoms of the disease

Two US medical bodies -- the National Institutes of Health and the Biomedical Advanced Research and Development Authority -- are currently working to plan such trials

But the FDA Commissioner Stephen Hahn later indicated that, while the drug has not yet been formally approved, access to it was being expanded so that authorities could gather more data

But whistleblowing doctor Li Wenliang, who died earlier this month from the virus, was punished for trying to sound the alarm on the outbreak in December

The vaccine could help eradicate malaria related cases and deaths

Malaria parasite cannot penetrate a human red blood cell when key proteins are deleted, Study finds

Most of vaccines that have been worked on have aimed to generate antibodies against the parasites